News Gene therapy for hearts gets FDA fast track Angionetics claims place among leaders in cardiovascular angiogenic gene therapy.
News Spark reassures on safety of haemophilia gene therapy Study of nine patients produce encouraging results
News Spark’s gene therapy shows great promise in restoring sight Philadelphia-based company could be frontrunner in gene therapy
Articles Digital healthcare round-up: Fitbit takes aim at medtech, ‘s... A round-up of this week's top digital healthcare news. Marco Ricci reports.
News ASH: AstraZeneca's dual-wielding CAR-T shows promise AstraZeneca has reported an impressive 96% response rate in the DURGA-1 of BCMAxCD19 CAR-T therapy AZD0120 in heavily pretreated multiple myeloma.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
